Business Standard

Pfizer may price Covid-19 vaccine lower in India than in UK and US

Cold chain of agriculture research body may come in handy

Pfizer, coronavirus vaccine
Premium

Lower price and infrastructure availability will ensure that doors remain open for the Pfizer vaccine to come to India for Covid-19 immunisation drive, according to sources

Sohini Das Mumbai
Global pharma major Pfizer may price its vaccine lower in India than in the UK and the US, sources in the know said. The government in the recent past had indicated that India wouldn’t be keen to procure the Pfizer-BioNTech vaccine because of its high cost and the extreme cold chain requirement at minus 70 degree Celsius.

Responding to the concern over the temperature requirement, a senior government official pointed out that India had cold chain infrastructure, owned by the Department of Agricultural Research and Education, that would be sufficient for a vaccine like the one developed by US-based Pfizer

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 16 2020 | 6:10 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com